AJMC October 18, 2024
Hayden E. Klein

Key Takeaways

  • Women face delayed diagnosis and suboptimal treatment due to differing symptom presentations and underrepresentation in cardiovascular trials.
  • Multidisciplinary approaches and remote monitoring are being implemented to improve women’s cardiovascular care and outcomes.
  • Initiatives like Vanderbilt’s Women’s Heart Center and Go Red for Women aim to address gender disparities in heart health.
  • More nationwide efforts are needed to ensure equitable cardiovascular care for women, addressing persistent knowledge gaps and treatment disparities.

The history of women being left out of heart disease research has had significant consequences on heart health care today.

Women being underrepresented in cardiovascular clinical trials has led to a knowledge gap of sex-based differences in heart disease.

With most early studies focusing on men,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Trends
Informed Consent, Inclusion Prioritized in Revised Ethics for Human Trials
Amy Abernethy, former No. 2 at FDA, outlines new company’s plans to streamline clinical research
The Data Chronicles | Behind the curtain | FDA and privacy considerations in clinical trial recruitment
Eximia Research acquires Integrated Clinical Trial Services
Managing Data from Clinical Trials: Q&A with Rust Felix

Share This Article